Fifteen more volunteers injected with COVIVAC candidate vaccine
Fifteen more volunteers have been inoculated with Vietnam’s second homegrown candidate vaccine COVIVAC on March 23 as part of its ongoing human trials.
A volunteer is given a shot of COVIVAC on March 23 (Photo: VNA)
Hanoi (VNA) – Fifteen more volunteers have been inoculatedwith Vietnam’s second homegrown candidate vaccine COVIVAC on March 23 as partof its ongoing human trials.
The candidate vaccine will be also injected into 15 othervolunteers on March 25.
Earlier on March 15, the first six out of the total 120volunteers took their shots of the vaccine, with their overall health checkedon March 22. They are now in stable health conditions and doing their work asnormal.
All the volunteers will receive their second shots 28 daysafter the first.
Developed by the Institute of Vaccines and MedicalBiologicals (IVAC) since last May, COVIVAC is the result of cooperation betweenIVAC and a number of partners, including the Hanoi Medical University, theIcahn School of Medicine at Mount Sinai in New York City, the University ofTexas in Austin, and the US-based health organisation PATH.
Using primary chicken embryo cell culture - a technique theinstitute used previously to successfully produce seasonal flu vaccines - it isthe second “made-in-Vietnam” candidate vaccine tested on humans.
The Nanogen Pharmaceutical Biotechnology Company earliercompleted the first phase of human trials of its NanoCovax vaccine and beganthe second phase on February 26./.
The Ministry of Health (MoH) on February 27 received 20 billion VND (866,620 USD) from conglomerate Vingroup for the clinical trials of homegrown COVID-19 vaccine COVIVAC.
People, aged from 18-59 and residing in Hanoi, can register for human trials of Vietnam’s second COVID-19 vaccine candidate COVIVAC from March 5 morning.
The Hanoi-based Vietnam Military Medical University and the Pasteur Institute in Ho Chi Minh City have completed the administration of the first doses of Nano Covax in the second-stage human trials of this homegrown COVID-19 candidate vaccine.
Six out of 120 volunteers have been injected with Vietnam’s second homegrown candidate vaccine COVIVAC, as human trials began at the Hanoi Medical University on March 15.
Standing members of the National Steering Committee for COVID-19 Prevention and Control have discussed the preparation of technical and policy solutions to implement the “COVID-19 vaccine passport” scheme while ensuring the principle of “safety first”.
Despite storm-related disruptions and flight delays, the organs were successfully transported via a combination of air and ground travel. All patients are currently stable and recovering well.
The patient, Tieu Viet But, born in 1970 and residing in Binh Tri commune, Binh Son district, the central province of Quang Ngai, was working aboard fishing vessel Qng – 95657TS when the incident occurred at 7:00 am.
All drugs entering hospitals must have a clear origin, so counterfeit drugs are only in the market, not in hospital, affirmed Minister of Health Dao Hong Lan.
To achieve its goal of becoming a developed nation by 2045, Vietnam is prioritising the integration of AI and digital tools into the training of future doctors, said Assoc. Prof. Dr. Nguyen Viet Nhung, Dean of Medicine at University of Medicine and Pharmacy, Vietnam National University (VNU) Hanoi.
Health experts called for collective disease prevention and integrated solutions to achieve zero dengue deaths in the country at an online talk show on June 14.
The PM called for closer, broader, and more effective cooperation with Vietnamese partners, guided by the principles of mutual benefit, joint efforts, shared outcomes, and common development, including promoting stronger public-private partnerships and collaboration with businesses.
Renowned for its expertise in complex surgeries, the hospital has attracted foreign patients seeking treatment for conditions such as kidney and urinary tract stones, urological and gastrointestinal cancers, and male reproductive disorders. Most procedures are performed using advanced techniques, including laparoscopy and robotic surgery. T
Leading Vietnamese companies specialising in respiratory and dermatological treatments, traditional medicine, immune support supplements, and functional foods will have an opportunity to connect with international distributors and secure export deals.
The project aimed to enable early detection and reduce the risk of dangerous complications, targeting patients with chronic diabetes, cardiovascular conditions and metabolic disorders.
A 2023 report by the Vietnam Health Economics Association estimated that the total cost of tobacco-related healthcare and economic losses reached 108 trillion VND (4.14 billion USD) annually – equivalent to 1.14% of GDP and five times higher than the budget revenue generated by the tobacco industry.
All eligible patients will receive surgical interventions and post-operative care in accordance with Vietnamese medical standards and global care protocols.
Medical screenings and surgical interventions for children with disabilities are being carried out at health centers across Dien Bien. So far this year, 242 children have been identified for diagnosis, treatment, surgery, and the provision of assistive devices.
The Red Journey has become the country’s largest and most effective blood donation campaign, leaving a strong impression on the national voluntary blood donation movement.
This case marks the ninth fetal cardiac intervention conducted in HCM City, and it was considered the most technically demanding to date due to the fetus’s extremely early gestational age and the severity of the condition as diagnosed with aortic atresia.
The groundbreaking ceremony took place one day after the VNVC Vaccine JS Company and Sanofi Group exchanged cooperation documents on vaccine production technology transfer under the witness of State President Luong Cuong and French President Emmanuel Macron.
Vietnam’s traditional medicine took centre stage at the International Congress Biopharm Nonclinical Development, BioNCiD 2025, held on May 25-26 in the Cuban city of Varadero, amid growing global interest in sustainable healthcare solutions.
Under the agreement, VNVC and Sanofi will gradually implement technology transfers to enable domestic production of several key Sanofi vaccines that are widely used in Vietnam. In addition, Sanofi will support VNVC in training human resources and quality management in vaccine research and manufacturing.
Despite the ongoing global circulation and unpredictable developments of SARS-CoV-2, the World Health Organisation (WHO) hasn’t issued new warnings about COVID-19, said the Ministry of Health.
A volunteer is given a shot of COVIVAC on March 23 (Photo: VNA) 
